| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZyVersa Therapeutics, Inc. | Chief Scientific Officer | Stock Options (right to buy) | 29,781 | 12 Dec 2022 | Direct | ||
| ZyVersa Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 18,094 | 12 Dec 2022 | Direct | ||
| ZyVersa Therapeutics, Inc. | Chief Scientific Officer | Warrant (right to buy) | 18,094 | 12 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | 12 Dec 2022 | 8 | $0 | 4 | Chief Scientific Officer | 14 Dec 2022, 18:31 |
| ZVSA | ZyVersa Therapeutics, Inc. | 12 Dec 2022 | 0 | $0 | 3 | Chief Scientific Officer | 13 Dec 2022, 09:41 |